AJP - Heart Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 288: H1976-H1981, 2005. First published December 9, 2004; doi:10.1152/ajpheart.00883.2004
0363-6135/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/4/H1976    most recent
00883.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krieg, T.
Right arrow Articles by Cohen, M. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krieg, T.
Right arrow Articles by Cohen, M. V.

Peptide blockers of PKG inhibit ROS generation by acetylcholine and bradykinin in cardiomyocytes but fail to block protection in the whole heart

Thomas Krieg,1,3 Sebastian Philipp,1 Lin Cui,1 Wolfgang R. Dostmann,4 James M. Downey,1 and Michael V. Cohen1,2

Departments of 1Physiology and 2Medicine, University of South Alabama College of Medicine, Mobile, Alabama; 3Department of Cardiology, Ernst-Moritz-Arndt Universität, Greifswald, Germany; and 4Department of Pharmacology, University of Vermont, Burlington, Vermont

Submitted 26 August 2004 ; accepted in final form 2 December 2004

Bradykinin and acetylcholine (ACh) trigger preconditioning by ATP-sensitive K+ (KATP) channel-dependent production of reactive oxygen species (ROS). Recent evidence suggests that ROS production may in turn be influenced by cGMP-dependent protein kinase (PKG). This study utilized DT-2 and DT-3 peptides, highly specific membrane-permeable blockers of PKG. Rabbit cardiomyocytes were incubated for 15 min in reduced MitoTracker red, which becomes fluorescent only after exposure to ROS. Bradykinin (400 nM) and ACh (250 µM) caused a 49.9 ± 5.9% and 46.8 ± 1.7% increase in ROS production, respectively (P < 0.005 vs. untreated cells). Coincubation with DT-3 (250 nM) abolished both the ACh- and bradykinin-induced ROS signal, whereas a nonpermeable form of the peptide (W45) had no effect on ACh-induced ROS production. DT-3 was unable to block ROS production from diazoxide (100 µM), a selective opener of mitochondrial KATP channels, suggesting that these channels are downstream of PKG. DT-2 (125 nM) also prevented ACh from triggering ROS production. 8-(4-Chlorophenylthio)-guanosine 3',5'-cyclic monophosphate (100 µM), a cGMP analog and potent direct activator of PKG, increased ROS production of cardiomyocytes by 44.7 ± 7.1% (P < 0.001 vs. untreated cells). This increase was blocked by DT-2. Neither DT-2 nor DT-3 could block the anti-infarct effect of bradykinin in isolated rabbit hearts. Studies with fluorescent-tagged DT-3 revealed that it was confined to endothelial cells and never reached the myocytes. We conclude that both bradykinin and ACh trigger ROS generation by a pathway that includes PKG. Although the peptides may be inappropriate for a whole heart model, they are likely to become important tool drugs for elucidation of signal transduction pathways in cell preparations.

protein kinase G; reactive oxygen species



Address for reprint requests and other correspondence: M. V. Cohen, Dept. of Physiology, MSB 3050, Univ. of South Alabama College of Medicine, Mobile, AL 36688 (E-mail: mcohen{at}usouthal.edu)




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. W. H. Pinkse, D. T. S. Rijkers, W. R. Dostmann, and A. J. R. Heck
Mode of Action of cGMP-dependent Protein Kinase-specific Inhibitors Probed by Photoaffinity Cross-linking Mass Spectrometry
J. Biol. Chem., June 12, 2009; 284(24): 16354 - 16368.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Pasdois, C. L. Quinlan, A. Rissa, L. Tariosse, B. Vinassa, A. D. T. Costa, S. V. Pierre, P. Dos Santos, and K. D. Garlid
Ouabain protects rat hearts against ischemia-reperfusion injury via pathway involving src kinase, mitoKATP, and ROS
Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1470 - H1478.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. J. Hausenloy and D. M. Yellon
Survival kinases in ischemic preconditioning and postconditioning
Cardiovasc Res, May 1, 2006; 70(2): 240 - 253.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.